Small Cap Gainers: BYSI, ATOM, CERS
1:49 pm Wednesday, August 04th, 2021
Beyondspring Inc (NASDAQ: BYSI) stock soared 188% to $27.70 after the company announced top-line results from its DUBLIN-3 Phase 3 trial of plinabulin in combination with docetaxel to treat 2nd and 3rd line non-small cell lung cancer compared to docetaxel alone; data showed that compared to docetaxel alone, the combination met the primary endpoint of increasing overall survival and met key secondary endpoints. Co intends to hold a pre-NDA meeting with the FDA in 2021. Upgraded to Buy at H.C. Wainwright. At multi-year highs.
Atomera Inc (NASDAQ: ATOM) is up 26% after the company provided a corporate update and disclosed Q2 results. Co’s adj. EBITDA for Q2 was $(2.9) mln vs $(3.0) mln in the prior-year quarter. Co stated that it made “strong progress” in its More-than-Moore focused technologies including MST-SP and RF-SOI.
Cerus Corporation (NASDAQ: CERS) stock moved up 21% after the company topped consensus for Q2 EPS and revs, reporting its highest quarterly total and product revs in co’s history, supported by the ramp of INTERCEPT platelet sales in the US. Raised its FY21 product revenue guidance to $118-122 mln from $110-114 mln.
